0
Clinical Investigations: INTERSTITIAL LUNG DISEASE |

Predicting Survival of Lung Transplantation Candidates With Idiopathic Interstitial Pneumonia*: Does Pao2 Predict Survival?

Suzanne J. Timmer, MD; Amir M. Karamzadeh, MD; G.L. Yung, MD, FCCP; Jolene Kriett, MD; Stewart W. Jamieson, MB, FCCP; Cecilia M. Smith, DO
Author and Funding Information

*From the Division of Pulmonary Medicine (Dr. Timmer), Naval Medical Center, San Diego, CA; the College of Medicine (Dr. Karamzadeh), University of California, Irvine, CA; the Divison of Pulmonary and Critical Care Medicine (Drs. Yung and Smith) and the Department of Surgery (Dr. Jamieson), Division of Cardiothoracic Surgery, University of California, San Diego Medical Center, San Diego, CA.

Correspondence to: Suzanne Timmer, MD, Naval Hospital Pensacola, Internal Medicine Department, 6000 W Highway 98, Pensacola, FL 32512; e-mail: timmersj@hotmail.com



Chest. 2002;122(3):779-784. doi:10.1378/chest.122.3.779
Text Size: A A A
Published online

Objective: To find a parameter that would discriminate between the patients with idiopathic interstitial pneumonia who survived to undergo transplantation and those who died while waiting to undergo transplantation.

Methods: A retrospective review was performed of all lung transplant referrals for idiopathic interstitial pneumonia that were listed with United Network for Organ Sharing at the University of California San Diego from January 1990 to February 1999. Of the 331 patients who were listed, 48 met the eligibility criteria. Patient demographics, radiographic studies, pathology reports, and the results of resting and exercise cardiopulmonary function tests were recorded from each patient’s chart. Patients were divided into the following two groups: those patients who survived until transplantation and those still waiting were classified as “alive”; and those patients who died before undergoing transplantation were classified as “deceased.” Results: Forty-three of 48 patients had a pathologic diagnosis. The cohort included 25 patients with usual interstitial pneumonitis, 3 patients with nonspecific interstitial pneumonitis, 1 patient with desquamative interstitial pneumonitis, and 14 patients with interstitial lung disease of unknown etiology. The only significant difference between the two groups was resting Pao2 (p = 0.035). A stepwise multivariate analysis demonstrated that Pao2 and FEV1/FVC ratio were significantly associated with survival (hazards ratio, 1.06; confidence interval, 0.99 to 1.13; p = 0.019).

Conclusions: A survival analysis using Pao2 and FEV1/FVC ratio values proved to be statistically significant, but a prospective trial is needed to determine the clinical relevance of these parameters for predicting survival in patients with idiopathic interstitial pneumonia.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543